Pulmonx Corp (NASDAQ: LUNG) on Tuesday, soared 14.22% from the previous trading day, before settling in for the closing price of $2.04. Within the past 52 weeks, LUNG’s price has moved between $1.31 and $9.37.
During the last 5-year period, the sales drop of Healthcare Sector giant was -19.80%. The company achieved an average annual earnings per share of -1.62%. With a float of $35.95 million, this company’s outstanding shares have now reached $41.25 million.
Pulmonx Corp (LUNG) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Pulmonx Corp is 6.92%, while institutional ownership is 77.72%. The most recent insider transaction that took place on Dec 08 ’25, was worth 46,409. In this transaction Director of this company sold 23,321 shares at a rate of $1.99, taking the stock ownership to the 93,910 shares. Before that another transaction happened on Dec 08 ’25, when Company’s Director proposed sale 23,321 for $1.99, making the entire transaction worth $46,385.
Pulmonx Corp (LUNG) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.33 earnings per share (EPS) for the period topping the consensus outlook (set at -0.45) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.12% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Pulmonx Corp (LUNG) is currently performing well based on its current performance indicators. A quick ratio of 4.15 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.34 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Looking closely at Pulmonx Corp (NASDAQ: LUNG), its last 5-days average volume was 1.19 million, which is a jump from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 80.16%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 39.69%, which indicates a significant decrease from 88.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.72, while its 200-day Moving Average is $3.27. However, in the short run, Pulmonx Corp’s stock first resistance to watch stands at $2.52. Second resistance stands at $2.71. The third major resistance level sits at $2.96. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $1.83. Now, if the price goes above the second support level, the third support stands at $1.64.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
Market capitalization of the company is 96.10 million based on 41,247K outstanding shares. Right now, sales total 83,790 K and income totals -56,390 K. The company made 21,500 K in profit during its latest quarter, and -13,960 K in sales during its previous quarter.
